Affiliation:
1. London Complex Mesh Centre, Directorate of Women's Health University College London Hospitals NHS Foundation Trust London UK
2. Female Pelvic Medicine and Reconstructive Surgery Research Group, Institute for Women's Health, Faculty of Population Sciences University College London London UK
3. Department of Uro‐Neurology National Hospital for Neurology and Neurosurgery London UK
Abstract
AbstractObjectiveTo analyze urodynamics findings and patient‐reported outcomes after removal of a mid‐urethral mesh because data regarding outcomes following mesh removal vary in different studies, and mesh removal itself may have risks.MethodsWomen who were referred to the Female Pelvic Medicine and Reconstructive Surgery Department of University College London Hospital and underwent vaginal removal of a continence mesh between January 2014 and January 2020, were included. Patient clinical data and results of video‐urodynamics investigations performed 4 months after mesh removal were collected and analyzed retrospectively.ResultsIn all, 204 patients were included in the study. After mesh removal, 80.5% of patients reported recurrent stress urinary incontinence (SUI), 10.1% reported prolapse symptoms, 8% reported voiding dysfunction and 2.9% reported overactive bladder (OAB) symptoms. Video‐urodynamics investigations confirmed the presence of SUI (67.6%), mixed urinary incontinence (14.3%), detrusor overactivity (DO) (6.8%) and voiding dysfunction in one patient. In two women a urethral stricture was described, and 10 women were deemed to have a significant cystocele.ConclusionRecurrence of SUI was the most frequent finding after continence mesh removal, both symptomatically and objectively. Women seldom reported OAB symptoms, but urodynamics showed evidence of DO despite this. On the other hand, voiding dysfunction was often reported but less often proven on urodynamics.
Subject
Obstetrics and Gynecology,General Medicine